Heat-treated and/or lysozyme-treated <i>Enterococcus faecalis</i> (FK-23) improves the progression of renal disease in a unilateral ischemia-reperfusion injury rat model-Reference-Cited by-同舟云学术

Heat-treated and/or lysozyme-treated <i>Enterococcus faecalis</i> (FK-23) improves the progression of renal disease in a unilateral ischemia-reperfusion injury rat model

Published:2024 Issue:1 Volume:75 Page:78-89
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Takemura Shigekazu¹,Minamiyama Yukiko²³,Ito Norihiko⁴,Yamamoto Atsushi⁵,Ichikawa Hiroshi³⁶,Nakagawa Kanako¹,Toyokuni Shinya⁷,Osada-Oka Mayuko²,Yoshikawa Toshikazu¹³⁸

Affiliation:

1. Department of Frontier Life-science, Graduate School of Medicine, Osaka Metropolitan University

2. Food Hygiene and Environmental Health Division of Applied Life Science, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University

3. Louis Pasteur Center for Medical Research

4. Animal Medical Center, Faculty of Agriculture, Tottori University

5. Faculty of Environmental Studies, Tottori University

6. Department of Medical System Protective Health and Medicine Laboratory, Graduate School of Life and Medical Sciences, Doshisha University

7. Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine

8. Department of Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Publisher

The Society for Free Radical Research Japan

Link

https://www.jstage.jst.go.jp/article/jcbn/75/1/75_24-29/_pdf

Reference26 articles.

1. 1 Kovesdy C, Schmedt N, Folkerts K, et al. Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors. BMC Med 2022; 20: 2.

2. 2 Takesue Y, Yokoyama T, Akagi S, et al. Changes in the intestinal flora after the administration of prophylactic antibiotics to patients undergoing a gastrectomy. Surg Today 2002; 32: 581–586.

3. 3 Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013; 83: 308–315.

4. 4 Barros AF, Borges NA, Ferreira DC, et al. Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients? Future Microbiol 2015; 10: 517–526.

5. 5 Oowada S, Endo N, Kameya H, Shimmei M, Kotake Y. Multiple free-radical scavenging capacity in serum. J Clin Biochem Nutr 2012; 51: 117–121.